Michael Baria: Is PRP Disease Modifying in Osteoarthritis?
Michael Baria, Lead for The Early Osteoarthritis and Joint Health Program at The Ohio State University Wexner Medical Center, Head Team Physician for Ohio State Wrestling at The Ohio State University Department of Athletics, shared a post on LinkedIn about a recent article by Jiabao Chu et al. published in KSSTA:
“Here is a study I don’t think has gotten nearly enough attention.
Chu et al randomized over 600 knee OA patients (that alone is a feat) to receive either 3, weekly LP-PRP (4 fold platelets) or saline placebo.
Beyond the usual symptom improvement, the imaging results are impressive.
At 5 years, the PRP group lost cartilage volume at half the rate compared to saline.
A single round of PRP reduced cartilage loss for 5 years.
Amazing.
Whereas 10 years ago, the party line was that PRP is still only modifying symptoms, we can put to bed the question ‘is PRP disease modifying?‘.
We have clear evidence it is.
More encouraging; this was disease modifying with only 1 round of treatment.
Most of our patients routinely seek care every 6-12 months so we have every expectation their outcomes are even better.”
Title: Intra-articular injections of platelet-rich plasma decrease pain and improve functional outcomes than sham saline in patients with knee osteoarthritis
Authors: Jiabao Chu, Weifeng Duan, Ziqiang Yu, Tao Tao, Jie Xu, Qianli Ma, Lingying Zhao, Jiong Jiong Guo
Read the Full Article on KSSTA
Stay updated on all scientific advances with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers